These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Levamisole therapy: clinical and immunological evaluation in herpetic keratitis.
    Author: Luzi G, Voci MC, Bonomo R, Aiuti F, Pivetti Pezzi P, Aziz M.
    Journal: Int J Immunopharmacol; 1983; 5(3):197-9. PubMed ID: 6618742.
    Abstract:
    Thirty patients with herpetic keratitis, recurrent in 17, were examined and submitted to an immunological evaluation for cell-mediated immunity (E rosette forming cells, absolute number of T lymphocytes, skin tests). A group of 15 patients was treated with Levamisole (2.5 mg/kg body weight, 3 days a week), while the control group received no Levamisole. The observation period varied from 6 to 24 months. The clinical follow-up showed a reduction in the severity and duration of herpetic attacks and in the frequency of relapses compared with the control group. The immunological findings indicated a normalization of E rosettes in all the patients (treated and controls).
    [Abstract] [Full Text] [Related] [New Search]